New pill targets rare gene fusion in Hard-to-Treat cancers
NCT ID NCT06010342
First seen Apr 28, 2026 · Last updated Apr 28, 2026
Summary
This study tests a new drug called TL118 for people with advanced solid tumors that have a specific gene change (NTRK fusion). The goal is to see if the drug can shrink tumors or slow their growth. About 60 adults whose cancer has worsened after other treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Adventist Health Glendale
RECRUITINGGlendale, California, 91206, United States
-
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, China
-
Affiliated Cancer Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang, China
-
Beijing Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Chongqing University Cancer Hospital
RECRUITINGChongqing, Chongqing Municipality, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, Fujian, China
-
Harbin medical university cancer hospital
RECRUITINGHarbin, Heilongjiang, China
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, China
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, Jiangxi, China
-
Jinan Central Hospital
RECRUITINGJinan, Shandong, China
-
Peking University School and Hospital of Stomatology
RECRUITINGBeijing, Beijing Municipality, China
-
Shanghai East Hospital
RECRUITINGShanghai, Shanghai Municipality, China
-
Shanxi Cancer Hospital
RECRUITINGXi'an, Shaanxi, China
-
Texas Oncology
RECRUITINGDallas, Texas, 75251, United States
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.